Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer DOI: 10.1038/s41591-019-0592-2
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial DOI: 10.1093/annonc/mdz122
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer DOI: 10.1016/j.ejca.2019.04.019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study DOI: 10.1038/s41591-019-0380-z
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics DOI: 10.1111/bph.14542
Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership DOI: 10.1002/cpt.657
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer DOI: 10.1038/nm.4239